Peripheralization of hematopoietic stem cells

Details Peripheralization of hematopoietic stem cells Peripheralization of hematopoietic stem cells

1993-11-15

2009-06-30

Ungar, Susan (Department: 1642)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C424S133100, C424S135100, C424S143100, C424S144100, C424S152100, C424S153100, C424S156100, C424S085100, C424S085200

Reissue Patent

active

RE040811

ABSTRACT:
The invention relates to in vivo peripheralization of CD34+cells by administering anti-VLA-4 antibodies or anti-VCAM-1 antibodies.

REFERENCES:
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5206345 (1993-04-01), Masinovsky
patent: 5695755 (1997-12-01), Papayannopoulou
patent: 5824304 (1998-10-01), Papayannopoulou
patent: 5871734 (1999-02-01), Lobb et al.
patent: 5888507 (1999-03-01), Burkly
patent: 5932214 (1999-08-01), Lobb et al.
patent: 6482409 (2002-11-01), Lobb et al.
patent: 7176184 (2007-02-01), Lobb et al.
patent: 2005/0208053 (2005-09-01), Burkly
patent: 2006/0013808 (2006-01-01), Lobb et al.
patent: 0 330 506 (1989-08-01), None
patent: 0 455 482 (1991-11-01), None
patent: 0 455 482 (1991-11-01), None
patent: 0 625 912 (1994-11-01), None
patent: 0 626 861 (1994-12-01), None
patent: 0 682 529 (1995-11-01), None
patent: WO 91/03252 (1991-03-01), None
patent: WO 93/13798 (1993-07-01), None
patent: WO 93/15764 (1993-08-01), None
patent: WO 94/17828 (1994-08-01), None
Williams et al (Nature, Aug. 1991, 352:438-441).
Issekutz (J of Immunology, Dec. 1991, 147:4178-4184).
Caux et al (Blood, 1992, 79:2628-2635).
Teixido et al., “Human CD34 + Progenitor Cell Adhesion to Marrow Stroma is Mediated by VLA-4/VCAM and VLA5/Fibronectin”,Blood, 78, Suppl. 1, p. 302a, abstract 1200 (1991).
Williams et al., “Fibronectin and VLA-4 in hematopoietic Stem Cells-Microenvironment Interactions”,Nature, 352, pp. 438-441 (1991).
Bednarczyk, J.L., et al., “Identification of a Combinatorial Epitope Expressed by the Integrin α4β1 Heterodimer Involved in the Regulation of Cell Adhesion,”J. Biol. Chem. 269:8348-8354, The American Society for Biochemistry and Molecular Biology, Inc. (Mar. 1994).
Bensinger, W., et al., “Autologous Transplantation with Peripheral Blood Mononuclear Cells Collected After Administration of Recombinant Granulocyte Stimulating Factor,”Blood 81:3158-3163, American Society of Hematology (Jun. 1993).
Berenson, R.J., “Transplantation of CD34+ Hematopoietic Precursors: Clinical Rationale,”Transplantation Proc. 24:3032-3034, Elsevier Science Inc. (Dec. 1992).
Bochner, B.S., et al., “Adhesion of Human Basophils, Eosinophils, and Neutrophils to Interleukin 1-activated Human Vascular Endothelial Cells: Contributions of Endothelial Cell Adhesion Molecules,”J. Exp. Med. 173:1553-1556, The Rockefeller University Press (Jun. 1991).
Bregni,M., et al., “Human Peripheral Blood Hematopoietic Progenitors are Optimal Targets of Retroviral-Mediated Gene Transfer,”Blood 80:1418-1422, American Society of Hematology (Sep. 1992).
Bronchud, M.H., et al., “In Vitro and In Vivo Analysis of the Effects of Recombinant Human Granulocyte Colony-Stimulating Factor in Patients,”Br. J. Cancer 58:64-69, American Society of Hematology (Apr. 1988).
Brugger, W., et al., “Ex Vivo Expansion of Enriched Peripheral Blood CD34+ Progenitor Cells by Stem Cell Factor, Interleukin-1β (IL-1β), IL-6, IL-3, Interferon-γ, and Erythropoietin,”Blood 81:2579-2584, American Society of Hematology (Apr. 1993).
Chao, N.J., et al., “Granulocyte Colony-Stimulating Factor ‘Mobilized’ Peripheral Blood Progenitor Cells Accelerate Granulocyte and Platelet Recovery After High-Dose Chemotherapy,”Blood 81:2031-2035, American Society of Hematology (Apr. 1993).
Craig, J.I., et al., “Peripheral Blood Stem Cell Transplantation,”Blood Rev.6:59-67, Churchill Livingstone (Jun. 1992).
DePalma, “CellPro, Inc. Tests Its Stem Cell-Therapy in Clinic Trials,”Genet. Eng. News 12,Mary Ann Liebert, Inc. (May 1992).
Denkers, I.A., et al., “VLA Molecule Expression May be Involved in the Release of Acute Myeloid Leukaemic Cells from the Bone Marrow,”Leukemia Res. 16:469-476, Elsevier Ltd. (May 1992).
Edgington, S.M., “New Horizons for Stem-Cell Bioreactors,”Biotechnol.10:1099-1106, Nature Publishing Company (Oct. 1992).
Elices, M.J., et al., “VCAM-1 on Activated Endothelium Interacts with the Leukocyte Integrin VLA-4 at a Site Distinct from the VLA-4/Fibronectin Binding Site,”Cell 60:577-584, Cell Press (1990).
European Opposition of EP Patent 0 625 912 document, Declaration of Dr. Roy Lobb, 2 pages (Mar. 13, 1999).
European Opposition of EP Patent 0 625 912 , Interlocutory Decision in Opposition Proceedings (Articles 102(3) and 106(3) EPC), 17 pages (Jun. 6, 2001).
European Appeal of EP Patent No. 0 625 912, Decision of the Technical Board of Appeal, 29 pages (Oct. 6, 2004).
European Opposition of EP Patent No. 0 626 861, Interlocutory Decision in Opposition Proceedings (Articles 102(3) and 106(3) EPC), 17 pages (Feb. 13, 2003).
European Appeal of EP Patent No. 0 626 861, Decision of the Technical Board of Appeal, 4 pages (Oct. 23, 2003).
European Opposition of EP Patent No. 0 682 529, Interlocutory Decision in Opposition Proceedings (Articles 102(3) and 106(3) EPC), 16 pages (May 28, 2001).
Gale, R.P., et al., “Blood Stem Cell Transplants Come of Age,”Bone Marrow Transplant. 9:151-155, Nature Publishing Group (Mar. 1992).
Gerhartz, H., “Zukunftspersperktiven von Knochenmarkund Stammzellaktivierung fur die autologe Transplantation,”Beitr. Infusionther. 28:254-258, Karger (1991).
Gillis, “Chap. 21. T-Cell-Derived Lymphokines” in :Fundamental Immunol.,Coleman, R.M., ed., McGraw-Hill Professional Publishing, New York, NY, pp. 621-638 (1989).
Haas, R., “Successful Autologous transplantation of Blood Stem Cells Mobilized with Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor,”Exp. Hematol. 18:94-98, Elsevier Science Inc. (Feb. 1990).
Hemler, M.E., “VLA Proteins in the Integrin Family: Structures, Functions, and Their Role on Leukocytes,”Annu. Rev. Immunol.8:365-400, Annual Reviews, Inc. (1990).
Kessinger, A. and Armitage, J.O., “The Evolving Role of Autologous Peripheral Stem Cell Transplantation Following High-Dose Therapy for Malignancies,”Blood 77:211-213, American Society of Hematology (Jan. 1991).
Korbling, M., “Die Tolleder Stammzell-Mobilisation im Rahmen der Autologen Blutstammzell-Transplantation,”Beitr. Infusionther. 28:233-241, Karger (1991).
Liesveld, J.L., et al., “Expression of Integrins and Examination of Their Adhesive Function in Normal and Leukemic Hematopoietic Cells,”Blood 81:112-121, American Society of Hematology (Jan. 1993).
Lobo, F., et al., “Addition of Peripheral Blood Stem Cells Collected Without Mobilization Techniques to Transplanted Autologous Bone Marrow Did Not Hasten Marrow Recovery Following Myeloablative Therapy,”Bone Marrow Transplant. 8:389-392, Nature Publishing Group (Nov. 1991).
Magrin, et al., “Collection, Processing and Storage of Peripheral Blood Stem Cells (PBSC),”Haematologica, Suppl 1, 76:55-57, Ferrata Storti Foundation (Mar. 1991).
Papayannoulou, T. and Nakamoto, B., “Peripheralization of hemopoietic Progenitors in Primates Treated with Anti-VLA4 Integrin,”Proc. Natl. Acad. Sci. USA 90L9374-9378, National Academy of Sciences (Oct. 1993).
Pulido, R., et al., “Functional Evidence for Three Distinct and Independently Inhibitable Adhesion Activities Mediated by the Human Integrin VLA-4. Correlation with Distinct α4 Epitopes,”J. Biol. Chem. 266:10241-10245, American Society for Biochemistry and Molecular Biology (Jun. 1991).
Rowe, J.M. and Rapoport, A.P., “Hemapoietic Growth Factors: A Review,”J. Clin. Pharmacol. 32:486-501, Sage Science Press (Jun. 1992).
Ryan, D.H., et al., “Inhibition of Human Bone Marrow Lymphoid Progenitor Colonies by Antibodies to VLA Integrins,”J. Immunol. 149:3759-3764, American Association of Immunologists (Dec. 1992).
Siena, S., et al., Circulation of CD34+ Hematopoietic Stem Cells in the Peripheral Blood of High-Dose Cyclophosphamide-Treated Patients: Enhancement by Intravenous Recombinant Human Granulocyte-Macrophage Co

Affiliated with

Also associated with

Rating

Peripheralization of hematopoietic stem cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peripheralization of hematopoietic stem cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peripheralization of hematopoietic stem cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4115261